US.IQV · IQVIA

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.8781126020309693,
        "turnoverUsdM": 233.83133905361998,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.IQV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 244.4872,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.8,
      "take_profit_price": 275.0248,
      "target_multiplier": 1.9,
      "technical_strength": 1.65,
      "take_profit_percent": 6
    },
    "positionPoints": 1.4,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.756225204061939,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 81.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 68.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 13
  },
  "market": {
    "ma20": 243.0455,
    "ma50": 216.105,
    "close": 259.42,
    "prevClose": 260.24,
    "avgVolume20": 1297683,
    "volumeRatio": 0.69,
    "changePercent": -0.32
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 13,
    "details": {
      "ret_5d": 0.08078161513469828,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 13,
      "vcp_bonus": 0,
      "vol_ratio": 0.5979422066549912,
      "ret_points": 12,
      "vol_points": 0,
      "range_ratio": 0.6128263318357238,
      "volat_points": 0,
      "day_range_pct": 0.020622850180292415,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 81.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 50,
        "contribution": 2.5
      },
      {
        "raw": 16.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 82,
        "contribution": 16.4
      },
      {
        "raw": 8.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 57.33,
        "contribution": 8.6
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 6.6,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 66,
        "contribution": 6.6
      },
      {
        "raw": 22,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 73.33,
        "contribution": 22
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "謹慎買入",
    "result": 68.1,
    "details": [
      "基本面分析總分: 2.5/5分",
      "資金流分析總分: 16.4/20分",
      "市場環境分析總分: 8.6/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 6.6/10分",
      "技術信號分析總分: 22/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 2.5,
      "資金流": 16.4,
      "市場環境": 8.6,
      "情緒分析": 6,
      "技術信號": 22,
      "風險管理": 6.6
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.3,
          "marginPoints": 0,
          "turnoverUsdM": 233.83133905361998,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "優秀",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 4,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.IQV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.85
            }
          },
          "trend": {
            "score": 2.4,
            "details": {
              "qqq": {
                "ma20": 712.1600008500002,
                "ma50": 713.0132008399997,
                "name": "QQQ",
                "close": 710.71997,
                "points": 0.4
              },
              "spy": {
                "ma20": 764.7984983,
                "ma50": 752.747003,
                "name": "SPY",
                "close": 765.90997,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.8781126020309693,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141202226,
                "url": "https://finnhub.io/api/news?id=b68daee5cfbfb169797e55d91888f60113a0b2a99cd2acf7556caffc4d5e57e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA shares jump 41.5% in three months as record R&DS bookings, a solid backlog, raised 2026 guidance and share buybacks support sentiment.",
                "category": "company",
                "datetime": 1786540140,
                "headline": "IQV Stock Gains 42% in 3 Months: Here's What You Should Know"
              },
              {
                "id": 141167081,
                "url": "https://finnhub.io/api/news?id=b700ebb447c78ea9e402e4bd24d63ac387587745f806398d196249a607bb6cf2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "In late July and early August 2026, IQVIA Holdings and Medera announced a collaboration pairing IQVIA’s global clinical and commercialization infrastructure with Medera’s Sardocor and Novoheart cardiac gene therapy and human-based drug discovery platforms, alongside IQVIA’s second-quarter results, raised full-year 2026 revenue guidance to between US$17.28 billion and US$17.48 billion, and continued share repurchases. The partnership’s focus on AAV-based cardiac gene therapies and Novoheart’s...",
                "category": "company",
                "datetime": 1786288282,
                "headline": "How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook"
              },
              {
                "id": 141105198,
                "url": "https://finnhub.io/api/news?id=6134f871b3f7a51976ba24fc6a3e3a59c939bac03ba67e375b3f87503a8e88b3",
                "image": "",
                "source": "Fintel",
                "related": "IQV",
                "summary": "",
                "category": "company",
                "datetime": 1785808596,
                "headline": "IQVIA Holdings (IQV) Price Target Increased by 19.30% to 277.88"
              },
              {
                "id": 141059860,
                "url": "https://finnhub.io/api/news?id=8b0df14c95ac015f563bb75483a7aa61e1b8944711b0288c10aa82c7b4fc692b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings just saw its internal fair value price target move from US$226.95 to US$232.00, a small reset in the reference point analysts are using. That shift sits against a mixed backdrop, with several firms lifting targets into the low to mid US$200s while at least one prominent analyst has moved to a more cautious US$200 view. As you read on, you will see how these changing targets fit into the evolving IQVIA story and what to watch as new research hits the tape. Analyst Price Targets...",
                "category": "company",
                "datetime": 1785366682,
                "headline": "IQVIA (IQV) Stock Sees Modest Fair Value Lift After Mixed Analyst Target Changes"
              },
              {
                "id": 141051618,
                "url": "https://finnhub.io/api/news?id=2c92bc38260f4a9d4e29594e08d3d8987013d3f814cd289baaa758832f19420f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings (IQV) stock moved after the company reported second quarter results that exceeded analyst estimates, raised full year 2026 revenue and earnings guidance, and expanded its share repurchase program, which highlighted management’s confidence in the business. See our latest analysis for IQVIA Holdings. The earnings beat and guidance raise have come on top of strong recent momentum, with a 90 day share price return of 55.07% and a 1 year total shareholder return of 24.87% suggesting...",
                "category": "company",
                "datetime": 1785316075,
                "headline": "IQVIA Holdings (IQV) Earnings Beat Keeps Fair Value In Focus"
              },
              {
                "id": 141050013,
                "url": "https://finnhub.io/api/news?id=194745d9a3831eca8301e4d7a9666c56b63ee319c6610b38b435d1ec2eac7e70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Shares of clinical research company IQVIA (NYSE: IQV) jumped 12.9% in the morning session after the company reported second-quarter results that surpassed Wall Street's expectations and raised its full-year guidance. The company posted revenue of $4.37 billion, an 8.7% increase year-over-year, which beat estimates of $4.30 billion. Its adjusted earnings per share came in at $3.15, up 12.1% from the previous year and topping the consensus estimate of $3.03.",
                "category": "company",
                "datetime": 1785295982,
                "headline": "IQVIA (IQV) Shares Skyrocket, What You Need To Know"
              },
              {
                "id": 141050014,
                "url": "https://finnhub.io/api/news?id=db3f9b76ac2a708e1cec7df90a76a9c27ffdeb6c3a2927fbb2890dcd3ce0346d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings Inc. (NYSE:IQV) extended its winning streak to a 4th straight session on Tuesday, jumping 13.94 percent to finish at $242.94 apiece after its higher revenue growth outlook and strong second-quarter performance reinforced investor confidence in its growth trajectory. In an updated report, the healthcare technology company said that it was able to grow […]",
                "category": "company",
                "datetime": 1785293756,
                "headline": "IQVIA Holdings (IQV) Soars on Revenue Growth Outlook, Strong Q2"
              },
              {
                "id": 141050015,
                "url": "https://finnhub.io/api/news?id=5f141f779aa8b0aa30cefa6dcbca841ac2b33f311b2c4add7fd0735bf0260055",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1785288601,
                "headline": "IQVIA (IQV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"
              }
            ],
            "raw_source": [
              {
                "id": 141282338,
                "url": "https://finnhub.io/api/news?id=3046de6b1d88ffc7420634e357f1d3676b81f55e4482259675c37a13227475f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Charles River's 33.3% monthly surge faces a higher bar as stronger bookings and guidance meet margin pressure and a premium valuation.",
                "category": "company",
                "datetime": 1787326620,
                "headline": "CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running?"
              },
              {
                "id": 141282331,
                "url": "https://finnhub.io/api/news?id=f9bf1ff32f273e8a38b58e32b61a45d16cead1cede2e9b01b5ae33390cddf5eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Despite already outperforming the broader market over the past year, IQVIA continues to enjoy strong backing from Wall Street, with analysts remaining highly optimistic about the stock’s future prospects.",
                "category": "company",
                "datetime": 1787316049,
                "headline": "IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish?"
              },
              {
                "id": 141282336,
                "url": "https://finnhub.io/api/news?id=41bf54cabe248e75886c89629fa1a0dc8afaee6e4e3c01253ee448bc253827ae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., August 20, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that its AI-enabled Clinical Decision Support Tool, developed in collaboration with Breakthrough T1D, has won the 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year.",
                "category": "company",
                "datetime": 1787260500,
                "headline": "IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year"
              },
              {
                "id": 141263724,
                "url": "https://finnhub.io/api/news?id=79817c6765abca477c158dde61718bc04fe3d602b4fecbff929b0a7fcd1bb05a",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.",
                "category": "company",
                "datetime": 1787252701,
                "headline": "Exploring the top movers within the S&P500 index during today's session."
              },
              {
                "id": 141262493,
                "url": "https://finnhub.io/api/news?id=e35621ca09fce0d3e1edebbfb4c083ea6617d2a571f2e19e5d99d4ad8722292d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1787243701,
                "headline": "Thursday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 141261028,
                "url": "https://finnhub.io/api/news?id=5b54ec56dfde684c05d3723c87da63c116166a04b8bff3d3ea948663950358c1",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2280454849/image_2280454849.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "Tempus AI remains a strong buy, driven by its unique flywheel business model and recent validation of its technology via the Personalis acquisition. Learn more about TEM stock here.",
                "category": "company",
                "datetime": 1787212800,
                "headline": "Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance"
              },
              {
                "id": 141282339,
                "url": "https://finnhub.io/api/news?id=ed5fb101c531497967986eccd9f6e064a8c1bd1727f9d4860f4496c10aa57327",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., August 17, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that it has been ranked No. 1 in Everest Group’s \"Top 50™ Pharmaceutical Technology Providers\" report for 2026.",
                "category": "company",
                "datetime": 1787001300,
                "headline": "IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group"
              },
              {
                "id": 141231125,
                "url": "https://finnhub.io/api/news?id=20166a2b2acd2263cfdbcc99fc419c59e514054bea615fc73fdbae8d84095aeb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445262091/image_1445262091.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.",
                "category": "company",
                "datetime": 1786867596,
                "headline": "IHF: Healthcare Dashboard For August"
              },
              {
                "id": 141205521,
                "url": "https://finnhub.io/api/news?id=6832e14b21f0874656f33283932f5bb0210df135957773398747c23a6f14a2bd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Well-known pharmaceutical companies such as  Merck  and  Pfizer  typically manage this complex process in house.  Medpace Holdings  which targets oncology, metabolic, cardiology, central nervous system, and anti-infective therapies, raised its 2026 revenue guidance on July’s second-quarter conference call to a midpoint of $2.85 billion, corresponding to a year-over-year increase of 13%.  Three months later, Medpace is in the pink: On the heels of second-quarter earnings, the stock is up 14%.",
                "category": "company",
                "datetime": 1786622460,
                "headline": "This Healthcare Services Stock Has 37% Upside"
              },
              {
                "id": 141200512,
                "url": "https://finnhub.io/api/news?id=00bc77a193caee8506d9c2f7e49efdf6fa5f4b117ad9f052361cece75a324ba4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Management raised its full-year forecast, but the market seems to be asking for more than a higher target.",
                "category": "company",
                "datetime": 1786562251,
                "headline": "Amgen Stock And The Price Of A Promise"
              },
              {
                "id": 141202226,
                "url": "https://finnhub.io/api/news?id=b68daee5cfbfb169797e55d91888f60113a0b2a99cd2acf7556caffc4d5e57e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA shares jump 41.5% in three months as record R&DS bookings, a solid backlog, raised 2026 guidance and share buybacks support sentiment.",
                "category": "company",
                "datetime": 1786540140,
                "headline": "IQV Stock Gains 42% in 3 Months: Here's What You Should Know"
              },
              {
                "id": 141183971,
                "url": "https://finnhub.io/api/news?id=e4c287cbdc846d32459bf189d2db32e7a5889c8eed8899b4255e36ca7c625a24",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359132436/image_1359132436.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "The Moat Index gained 3.96%, outperforming the S&P 500 as its lower mega-cap technology exposure and financials tilt paid off.",
                "category": "company",
                "datetime": 1786432380,
                "headline": "Rotation Away From Tech Lifts Moat Index In July"
              },
              {
                "id": 141167081,
                "url": "https://finnhub.io/api/news?id=b700ebb447c78ea9e402e4bd24d63ac387587745f806398d196249a607bb6cf2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "In late July and early August 2026, IQVIA Holdings and Medera announced a collaboration pairing IQVIA’s global clinical and commercialization infrastructure with Medera’s Sardocor and Novoheart cardiac gene therapy and human-based drug discovery platforms, alongside IQVIA’s second-quarter results, raised full-year 2026 revenue guidance to between US$17.28 billion and US$17.48 billion, and continued share repurchases. The partnership’s focus on AAV-based cardiac gene therapies and Novoheart’s...",
                "category": "company",
                "datetime": 1786288282,
                "headline": "How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook"
              },
              {
                "id": 141137403,
                "url": "https://finnhub.io/api/news?id=d33bb730db92458aede3898cad23da737b5e15192590a4fa7b5c465aeb9c2d81",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "By Exec Edge Editorial Staff IQVIA (NYSE: IQV) and clinical-stage biopharmaceutical company Medera Inc. announced a strategic collaboration aimed at accelerating the development of cardiac gene therapies and human-based drug discovery platforms. Under the partnership, Medera’s Sardocor unit will use IQVIA’s clinical trial, regulatory and commercialization capabilities to advance FDA-cleared, first-in-human gene therapy programs targeting […] The post IQVIA, Medera Partner to Accelerate Developme",
                "category": "company",
                "datetime": 1786033851,
                "headline": "IQVIA, Medera Partner to Accelerate Development of Cardiac Gene Therapies"
              },
              {
                "id": 141137404,
                "url": "https://finnhub.io/api/news?id=8bcacff1340b1ee2b95e5365307464a552c516e4495f9696779383de56335945",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "ICLR's discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.",
                "category": "company",
                "datetime": 1786030140,
                "headline": "Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?"
              },
              {
                "id": 141137405,
                "url": "https://finnhub.io/api/news?id=47afe32156f9367ed564e74151247f9694747a064c2f2afb2f54f263b859c781",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Fiserv's Q2 revenues miss estimates and margin pressure leads to an earnings miss and cuts in its 2026 growth and profit outlook.",
                "category": "company",
                "datetime": 1786029540,
                "headline": "FISV Q2 Earnings Miss Estimates on Margin Pressure, Revenues Decline"
              },
              {
                "id": 141135703,
                "url": "https://finnhub.io/api/news?id=8b92e76d064223b51e30e268457878ddd8fc4636ae6f2e175f98a905ddc3b210",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Medpace pairs double-digit growth, record awards and a strong balance sheet with a rich valuation, raising the question of whether the premium already prices in its outlook.",
                "category": "company",
                "datetime": 1786027620,
                "headline": "Is MEDP Worth Buying as Growth Collides With a Premium Valuation?"
              },
              {
                "id": 141179008,
                "url": "https://finnhub.io/api/news?id=4d69bd668bd005ec76f504618066995db649d36404ed5f297cbdc4ef3cdca637",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Generative AI In Clinical Trials Market size & share revenue was valued at approximately USD 0.74 Billion in 2025 and is expected to reach USD 0.81 Billion in 2026 and is expected to reach around USD 1.86 Billion by 2035, at a CAGR of 9.63% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are IQVIA Holdings I",
                "category": "company",
                "datetime": 1785947400,
                "headline": "[Latest] Global Generative AI In Clinical Trials Market Size/Share Worth USD 1.86 Billion by 2035 at a 9.63% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"
              },
              {
                "id": 141124432,
                "url": "https://finnhub.io/api/news?id=5440a1d9664ae5dfee60475fc2d5b33ff34b84156c5b8d88613fc9f570e7098f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "ICON's 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.",
                "category": "company",
                "datetime": 1785941760,
                "headline": "ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen"
              },
              {
                "id": 141122740,
                "url": "https://finnhub.io/api/news?id=9bedb0e7ad3557d38250e6b6078562a1c573156c59f30cc48eac42ccf7f496b6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Medpace posted record Q2 awards and a stronger book-to-bill ratio, but can backlog conversion and study timing turn renewed demand into stronger 2027 growth?",
                "category": "company",
                "datetime": 1785940380,
                "headline": "Can MEDP's Record Q2 Bookings Build a Stronger Growth Path for 2027?"
              },
              {
                "id": 141115057,
                "url": "https://finnhub.io/api/news?id=121ceb4c7f84a1b1eba95308402c93bb368801ea41847207c1375f054515c114",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C. and BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company pioneering next-generation therapeutics for cardiovascular disease, today announced a strategic collaboration to accelerate the development of cardiac gene therapies and human-based d",
                "category": "company",
                "datetime": 1785874500,
                "headline": "IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery"
              },
              {
                "id": 141112004,
                "url": "https://finnhub.io/api/news?id=f2e3289fcc7b512fd956d37e9feedc7b131aba8866a1a1fb053c92c56c92bbce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQV's proprietary data platform and expanding clinical research business support growth, but high debt and liquidity risks keep the investment outlook balanced.",
                "category": "company",
                "datetime": 1785861180,
                "headline": "Is IQVIA Stock a Buy as Growth Improves but High Leverage Persists?"
              },
              {
                "id": 141112005,
                "url": "https://finnhub.io/api/news?id=7e679b3c0de0f9754a7138b3e31934ba7d1b73b3992f19e1ce072724291dadae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQV shares jump after Q2 earnings beat, record bookings and higher 2026 guidance, but future gains hinge on execution and backlog conversion.",
                "category": "company",
                "datetime": 1785859080,
                "headline": "Why IQVIA Stock Jumped 13% in a Week and Whether the Gains Can Last"
              },
              {
                "id": 141110285,
                "url": "https://finnhub.io/api/news?id=b3fd3f58fdd6f36ca1bf5e782d4cd18c14675e3fe944d57f94805080e713c400",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "The global healthcare ecosystem in 2026 is leading to a strong recovery in clinical research, with global pharma R&D investment topping $250 billion and the clinical research organization (CRO) market rising to $72 billion at roughly a 9% annual pace. As biopharma companies move capital into complex biologic pipelines, AI-powered trial improvement, and practical data […]",
                "category": "company",
                "datetime": 1785851950,
                "headline": "The Backlog Tells the Real Story: Inside IQVIA’s Blowout Q2"
              },
              {
                "id": 141108867,
                "url": "https://finnhub.io/api/news?id=78ddae8077cc5f0589c7594f8b850562c55f1b2b912b00ec9b62b63061e25a7f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding up shares.",
                "category": "company",
                "datetime": 1785847522,
                "headline": "1 Surging  Stock with Exciting Potential and 2 Facing Challenges"
              },
              {
                "id": 141105198,
                "url": "https://finnhub.io/api/news?id=6134f871b3f7a51976ba24fc6a3e3a59c939bac03ba67e375b3f87503a8e88b3",
                "image": "",
                "source": "Fintel",
                "related": "IQV",
                "summary": "",
                "category": "company",
                "datetime": 1785808596,
                "headline": "IQVIA Holdings (IQV) Price Target Increased by 19.30% to 277.88"
              },
              {
                "id": 141095267,
                "url": "https://finnhub.io/api/news?id=f350808dd5ecf511d461aff5d89e32ae896b3d84c3b5e02e69ec1ebbf1371bdc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "This insider disposed of 16% of direct holdings at $245.21 per share, while maintaining nearly 3,000 shares valued at $740,000.",
                "category": "company",
                "datetime": 1785701528,
                "headline": "An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know"
              },
              {
                "id": 141095268,
                "url": "https://finnhub.io/api/news?id=202fd2370bac91bca4d2ead72ed64f1a65df5794df88a1b16c594a4f7187fcde",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Sherbet's disposition leaves him with 20,999 directly held shares valued at $5.2 million as IQVIA trades near $238.",
                "category": "company",
                "datetime": 1785700964,
                "headline": "An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know"
              },
              {
                "id": 141094831,
                "url": "https://finnhub.io/api/news?id=b57de5cabe7b6706d5881eaca7fea578b3df80b2c5e471525072242a025d53bd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Bousbib exercised expiring stock appreciation rights while maintaining about 1.4 million shares in total beneficial ownership.",
                "category": "company",
                "datetime": 1785700305,
                "headline": "An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion"
              },
              {
                "id": 141087207,
                "url": "https://finnhub.io/api/news?id=79e77c460a159b12b5fdb784f7c44efc0b1aefa6cfa1fa600377134cf99ef33f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "After a whipsaw end to the month, the stock market’s decline was highlighted by the worst month for chip stocks in 24 years.",
                "category": "company",
                "datetime": 1785532200,
                "headline": "S&P 500 ends with its first July decline since 2014. Here are the stocks that led the selloff."
              },
              {
                "id": 141059860,
                "url": "https://finnhub.io/api/news?id=8b0df14c95ac015f563bb75483a7aa61e1b8944711b0288c10aa82c7b4fc692b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings just saw its internal fair value price target move from US$226.95 to US$232.00, a small reset in the reference point analysts are using. That shift sits against a mixed backdrop, with several firms lifting targets into the low to mid US$200s while at least one prominent analyst has moved to a more cautious US$200 view. As you read on, you will see how these changing targets fit into the evolving IQVIA story and what to watch as new research hits the tape. Analyst Price Targets...",
                "category": "company",
                "datetime": 1785366682,
                "headline": "IQVIA (IQV) Stock Sees Modest Fair Value Lift After Mixed Analyst Target Changes"
              },
              {
                "id": 141056814,
                "url": "https://finnhub.io/api/news?id=bb1bf94626f03cca28389e7e6fe5c88465086c1c85d94ab402cabc33e65afe87",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "JP Morgan  analyst Casey Woodring   maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $225 to $285.",
                "category": "company",
                "datetime": 1785335383,
                "headline": "JP Morgan Maintains Overweight on IQVIA Holdings, Raises Price Target to $285"
              },
              {
                "id": 141056815,
                "url": "https://finnhub.io/api/news?id=72f8fff64224c074b128cddd4583b4a9c302dc8311e66df122f3d7345090faf1",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "Stifel  analyst Shlomo Rosenbaum   maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $220 to $276.",
                "category": "company",
                "datetime": 1785334608,
                "headline": "Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $276"
              },
              {
                "id": 141054227,
                "url": "https://finnhub.io/api/news?id=808a2a15e87388c70c0d9ba28cc2b9151c898dc386ae6d4a3029c9a5301173d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "WM beats Q2 earnings estimates as pricing and efficiency lift margins, but softer volumes lead revenues to miss expectations.",
                "category": "company",
                "datetime": 1785333480,
                "headline": "WM Earnings Beat on Pricing in Q2, Revenues Miss Estimates"
              },
              {
                "id": 141054410,
                "url": "https://finnhub.io/api/news?id=04910910a200303e11da8a6e0a36df18f9b83a97226d252789452b7eec9cfa4a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "VRSK beats Q2 earnings and revenue estimates as subscription growth, Underwriting and Claims gains, and cost discipline supported the results.",
                "category": "company",
                "datetime": 1785333300,
                "headline": "Verisk Earnings Surpass Estimates in Q2 on Insurance Growth"
              },
              {
                "id": 141056816,
                "url": "https://finnhub.io/api/news?id=0e02c83a45858969865d66c8e344b692c63bc1d877032a90438ea3f928813487",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "TD Cowen  analyst Charles Rhyee   maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $233 to $288.",
                "category": "company",
                "datetime": 1785333234,
                "headline": "TD Cowen Maintains Buy on IQVIA Holdings, Raises Price Target to $288"
              },
              {
                "id": 141056817,
                "url": "https://finnhub.io/api/news?id=19b120acdf2f2002b4e561743ad2917b5bfeb5a29368be144583bddf250716c0",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "RBC Capital  analyst Ryan Halsted   maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $221 to $247.",
                "category": "company",
                "datetime": 1785332025,
                "headline": "RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $247"
              },
              {
                "id": 141053316,
                "url": "https://finnhub.io/api/news?id=94d315a824017d568a04fb1de27aba238cdea8e4ad5dadbdcb2abd69a9af4469",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1257845213/image_1257845213.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "IQVIA Holdings Inc. analysis: clinical trials & healthcare data leader. Key risks—slowing guidance, CSMS weakness, regulatory threats. Click for an IQV update.",
                "category": "company",
                "datetime": 1785319190,
                "headline": "IQVIA: A Great Business At The Wrong Price (Rating Downgrade)"
              },
              {
                "id": 141056818,
                "url": "https://finnhub.io/api/news?id=fc3229b0a80b7743cf4d168fb0bc70f48e39fb49f7e9d4a03768dfc1ccc25078",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "BMO Capital  analyst Sean Dodge   maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $210 to $270.",
                "category": "company",
                "datetime": 1785319007,
                "headline": "BMO Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $270"
              },
              {
                "id": 141051618,
                "url": "https://finnhub.io/api/news?id=2c92bc38260f4a9d4e29594e08d3d8987013d3f814cd289baaa758832f19420f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings (IQV) stock moved after the company reported second quarter results that exceeded analyst estimates, raised full year 2026 revenue and earnings guidance, and expanded its share repurchase program, which highlighted management’s confidence in the business. See our latest analysis for IQVIA Holdings. The earnings beat and guidance raise have come on top of strong recent momentum, with a 90 day share price return of 55.07% and a 1 year total shareholder return of 24.87% suggesting...",
                "category": "company",
                "datetime": 1785316075,
                "headline": "IQVIA Holdings (IQV) Earnings Beat Keeps Fair Value In Focus"
              },
              {
                "id": 141051573,
                "url": "https://finnhub.io/api/news?id=ddd6e8630fda370e634a7f87af7f51876628837204e2e9be458e5fe726ebd311",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "The Morning Bull - US Market Morning Update Wednesday, Jul, 29 2026 US stock futures are mixed in early Tuesday trade, with broad S&P 500 contracts slightly in the red while Dow futures edge up. The key driver is the US 10 year Treasury yield hovering around 4.64% as investors brace for this week’s Federal Reserve decision. Markets see roughly a one in three chance of a rate hike now and about a 56% chance by September. At the same time, US durable goods orders for June rose 0.3% and a core...",
                "category": "company",
                "datetime": 1785312551,
                "headline": "US Stock Market Today: S&P 500 Futures Slip As Fed Rate Uncertainty Builds"
              },
              {
                "id": 141056819,
                "url": "https://finnhub.io/api/news?id=d2dfbfdd54326d75719861df238e0e30e0453a0b1f6432abc89f7d072a636e98",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "Baird  analyst Eric Coldwell   maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $252 to $287.",
                "category": "company",
                "datetime": 1785309871,
                "headline": "Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $287"
              },
              {
                "id": 141050013,
                "url": "https://finnhub.io/api/news?id=194745d9a3831eca8301e4d7a9666c56b63ee319c6610b38b435d1ec2eac7e70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Shares of clinical research company IQVIA (NYSE: IQV) jumped 12.9% in the morning session after the company reported second-quarter results that surpassed Wall Street's expectations and raised its full-year guidance. The company posted revenue of $4.37 billion, an 8.7% increase year-over-year, which beat estimates of $4.30 billion. Its adjusted earnings per share came in at $3.15, up 12.1% from the previous year and topping the consensus estimate of $3.03.",
                "category": "company",
                "datetime": 1785295982,
                "headline": "IQVIA (IQV) Shares Skyrocket, What You Need To Know"
              },
              {
                "id": 141050014,
                "url": "https://finnhub.io/api/news?id=db3f9b76ac2a708e1cec7df90a76a9c27ffdeb6c3a2927fbb2890dcd3ce0346d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings Inc. (NYSE:IQV) extended its winning streak to a 4th straight session on Tuesday, jumping 13.94 percent to finish at $242.94 apiece after its higher revenue growth outlook and strong second-quarter performance reinforced investor confidence in its growth trajectory. In an updated report, the healthcare technology company said that it was able to grow […]",
                "category": "company",
                "datetime": 1785293756,
                "headline": "IQVIA Holdings (IQV) Soars on Revenue Growth Outlook, Strong Q2"
              },
              {
                "id": 141050015,
                "url": "https://finnhub.io/api/news?id=5f141f779aa8b0aa30cefa6dcbca841ac2b33f311b2c4add7fd0735bf0260055",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1785288601,
                "headline": "IQVIA (IQV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"
              },
              {
                "id": 141049168,
                "url": "https://finnhub.io/api/news?id=dd5e02769d1fa6cd538294047afcb3f217eb2e20e4685ecc07574e03f13a58f5",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "2026-07-28. The following slide deck was published by IQVIA Holdings Inc.",
                "category": "company",
                "datetime": 1785276082,
                "headline": "IQVIA Holdings Inc. 2026 Q2 - Results - Earnings Call Presentation"
              },
              {
                "id": 141047531,
                "url": "https://finnhub.io/api/news?id=c25c65c08950177641b189425212b026d485862677db24cc08b655531a421a9f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings Inc (IQV) reports robust financial performance with significant gains in R&D Solutions and AI advancements driving future growth.",
                "category": "company",
                "datetime": 1785272445,
                "headline": "IQVIA Holdings Inc (IQV) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and AI-Driven ..."
              },
              {
                "id": 141047462,
                "url": "https://finnhub.io/api/news?id=b5abd489913b7a3cb8817e844e23c63ac0671174db85469d33677a8aac4c72f1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "US equity indexes were mixed Tuesday as crude oil prices fell and semiconductor stocks led a pullbac",
                "category": "company",
                "datetime": 1785269443,
                "headline": "US Equity Markets Mixed as Oil Drops, Chip Shares Slide"
              },
              {
                "id": 141046481,
                "url": "https://finnhub.io/api/news?id=5a789a303e4ecdd3b2f3c352f51fde10cd7f853a76114434852d9f67bba1d749",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Healthcare stocks were higher late Tuesday afternoon, with the NYSE Healthcare Index rising 2.3% and",
                "category": "company",
                "datetime": 1785267594,
                "headline": "Sector Update: Healthcare Stocks Gain Late Afternoon"
              },
              {
                "id": 141046482,
                "url": "https://finnhub.io/api/news?id=a871c5ef34311290b5004faee309c1117bd748ebd7c3c2cc9813045911380f30",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (NYSE:IQV) reported second-quarter results that exceeded the high end of its guidance, supported by accelerating organic revenue growth, higher R&D Solutions bookings and operational productivity gains. The company also raised its full-year outlook for revenue, adjusted EBITDA and adjusted dil",
                "category": "company",
                "datetime": 1785265462,
                "headline": "IQVIA Q2 Earnings Call Highlights"
              },
              {
                "id": 141045086,
                "url": "https://finnhub.io/api/news?id=f8d3fbd852b3bfed4a2c538219c114f034c4a26df4a26adfcc8c7aeba5db644d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Moby summary of IQVIA Holdings Inc.'s Q2 2026 earnings call",
                "category": "company",
                "datetime": 1785260945,
                "headline": "IQVIA Holdings Inc. Q2 2026 Earnings Call Summary"
              },
              {
                "id": 141045347,
                "url": "https://finnhub.io/api/news?id=11117e0446259cc0de0632a25394b44177c47beecabedd4c35230e936776b46e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "(Updates with index/price moves, macroeconomic data, and company/geopolitical news from the first pa",
                "category": "company",
                "datetime": 1785260118,
                "headline": "Update: US Equity Indexes Mixed as Chipmakers Restrain Nasdaq, Crude Oil Slides"
              },
              {
                "id": 141044671,
                "url": "https://finnhub.io/api/news?id=60d82d912a0cbbf84300ba4e349dd2be3cc82511f788156598ee6f9cfa8ab719",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.",
                "category": "company",
                "datetime": 1785258300,
                "headline": "Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below."
              },
              {
                "id": 141046483,
                "url": "https://finnhub.io/api/news?id=cce4d10845fc38523572ee95432164cd7d7657aeeff5cd9273aabc9766224a51",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings leads the index after the company boosted its full-year outlook on the back of a strong second quarter.",
                "category": "company",
                "datetime": 1785257040,
                "headline": "This Healthcare Stock Is Today’s Best in the S&P 500"
              },
              {
                "id": 141044608,
                "url": "https://finnhub.io/api/news?id=d914c07964c6e02bbb3d0f3dab99f42869b3f4d48013c90488f66bd1641dc6d2",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.",
                "category": "company",
                "datetime": 1785256501,
                "headline": "Tuesday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 141046756,
                "url": "https://finnhub.io/api/news?id=5277ac9ce5ab09c91775e4401eb527b01d4297eeaa699861cf932ebc2b1419a0",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "IQVIA Holdings Inc. (IQV) Q2 2026 Earnings Call July 28, 2026 9:00 AM EDTCompany ParticipantsAri Bousbib - CEO & ChairmanMichael Fedock - Executive VP...",
                "category": "company",
                "datetime": 1785255794,
                "headline": "IQVIA Holdings Inc. (IQV) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141045580,
                "url": "https://finnhub.io/api/news?id=aab4e2a27736a9b16bc9e1f2aa0a043df816ed5a1f45075caa917b01d80eff5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Shares of Iqvia surged past a buy point Tuesday after the provider of clinical research services beat second-quarter estimates and raised guidance.  The consensus earnings estimate was $3.03 per share, with the highest estimate at $3.08, according to FactSet.  The backlog for its Research & Development Solutions business (which handles clinical trials) was $34.2 billion.",
                "category": "company",
                "datetime": 1785254668,
                "headline": "Clinical Trials Provider Soars, Clears Buy Point On Solid Q2 Results"
              },
              {
                "id": 141044064,
                "url": "https://finnhub.io/api/news?id=9937ae55e79b7180c264903b2cdb06c36f1746c2fed3883d2cc107218b59e849",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA's Q2 earnings beat estimates as record R&D bookings, broad-based growth and stronger demand support a raised 2026 outlook.",
                "category": "company",
                "datetime": 1785249600,
                "headline": "IQV Q2 Earnings Beat Estimates on R&D Bookings, Guidance Raised"
              },
              {
                "id": 141043102,
                "url": "https://finnhub.io/api/news?id=4def2ebd595d4441db1c358c20ea98221169d771dcb6942e98c2c7ed2cec1c4c",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1785249301,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 141044898,
                "url": "https://finnhub.io/api/news?id=3c4f2118fecab317dd2f02063642b4d41f4475fd1d3ee559a5000ef9c79f2978",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/28/Stock-Market.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "A deepening chip rout drags the Nasdaq while Coca-Cola and Sherwin-Williams beats power the Dow; oil dives 5% on Iran diplomacy as the Fed meets.",
                "category": "company",
                "datetime": 1785244866,
                "headline": "Nasdaq 100 Enters Correction, SanDisk Sinks Over 50% From Peak: Stock Market Today"
              },
              {
                "id": 141044750,
                "url": "https://finnhub.io/api/news?id=27cb745e303f84f2c2b413c130b9d57fbd931068eff4ca7d6c30d1e89bd4363f",
                "image": "https://image.cnbcfm.com/api/v1/image/108291907-1776272208596-gettyimages-2270824972-GERMANY_AIX.jpeg?v=1776272295&w=1920&h=1080",
                "source": "CNBC",
                "related": "IQV",
                "summary": "Here are some of the companies making headlines in midday trading.",
                "category": "company",
                "datetime": 1785243995,
                "headline": "Stocks making the biggest moves midday: Boeing, Amkor, Corning, Sandisk, IQVIA & more"
              },
              {
                "id": 141042104,
                "url": "https://finnhub.io/api/news?id=11f0cec0ad2f7223e331da656e37556b5435aa3a806c3986528cfcefe7d5c8bb",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.",
                "category": "company",
                "datetime": 1785242101,
                "headline": "These S&P500 stocks are moving in today's pre-market session"
              },
              {
                "id": 141042030,
                "url": "https://finnhub.io/api/news?id=4f064d33c0210b4ea674ad29caefe64ab2e9245092b8af8e2bbfb1686207a391",
                "image": "https://www.chartmill.com/images/uploads/earnings_article_1_defce97180.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "IQVIA beat Q2 profit estimates with $3.15 EPS, raised full-year guidance, and saw record bookings, sending shares up 8.8% pre-market.",
                "category": "company",
                "datetime": 1785241427,
                "headline": "IQVIA (NYSE:IQV): Quality Stock Surges on Q2 Earnings Beat and Raised Outlook"
              },
              {
                "id": 141042762,
                "url": "https://finnhub.io/api/news?id=ad123dfea8481fe294b79a94e06ead627e3253f7ea3667962bfcb0fba028938f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (IQV) delivered earnings and revenue surprises of +4.31% and +1.63%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785240902,
                "headline": "IQVIA Holdings (IQV) Q2 Earnings and Revenues Beat Estimates"
              },
              {
                "id": 141042763,
                "url": "https://finnhub.io/api/news?id=27339bb7c84168fd71e48447cc62688f18a1556ce0702a5af5c8d0311f8dfed3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 8.7% year on year to $4.37 billion. The company’s full-year revenue guidance of $17.38 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $3.15 per share was 3.9% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785239866,
                "headline": "IQVIA’s (NYSE:IQV) Q2 CY2026 Sales Top Estimates, Stock Soars"
              },
              {
                "id": 141041873,
                "url": "https://finnhub.io/api/news?id=78b6da8d36a470407f55ea041853fe1042bd75da9e2e808fb2f59871bf428795",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., July 28, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended June 30, 2026.",
                "category": "company",
                "datetime": 1785236400,
                "headline": "IQVIA Reports Second-Quarter 2026 Results"
              },
              {
                "id": 141043191,
                "url": "https://finnhub.io/api/news?id=00685670d37a3258726cf439f1b6b29961ec0c78a519563576c46c67c394c2c4",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/28/Display-Of-Stock-Market-Quotes.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting better-than-expected earnings and raising FY26 guidance.",
                "category": "company",
                "datetime": 1785233140,
                "headline": "Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday"
              },
              {
                "id": 141043988,
                "url": "https://finnhub.io/api/news?id=a4ae6a30cf738f4fa9aef0535aa6fc7f86ae73596ae528536881703a10513978",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "Gainers\n\nGossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million. \nPrelude Therapeutics (NASDAQ:PRLD) shares moved",
                "category": "company",
                "datetime": 1785225958,
                "headline": "12 Health Care Stocks Moving In Tuesday's Pre-Market Session"
              },
              {
                "id": 141046701,
                "url": "https://finnhub.io/api/news?id=743d4441c1807855bdd9dc4f3258113596f78c7178e6f390ff57dc8aca2faadc",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $3.15 per share which beat the analyst consensus estimate of $3.03 by 3.96 percent. This is a 12.1 percent increase over earnings of $2.81 per share from the same",
                "category": "company",
                "datetime": 1785222109,
                "headline": "IQVIA Hldgs Q2 Adj. EPS $3.15 Beats $3.03 Estimate, Sales $4.368B Beat $4.301B Estimate"
              },
              {
                "id": 141046702,
                "url": "https://finnhub.io/api/news?id=2f53a53eea6b97fc62363a9a606bf9f043c3804d3a93c5313ceac615ed776158",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 analyst estimate. Raises FY2026 sales outlook from $17.150 billion-$17.350 billion to $17.275 billion-$17.475",
                "category": "company",
                "datetime": 1785222100,
                "headline": "IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 Est; Raises FY2026 Sales Guidance from $17.150B-$17.350B to $17.275B-$17.475B vs $17.286B Est"
              },
              {
                "id": 141030716,
                "url": "https://finnhub.io/api/news?id=fe6ae75100661458ba44b3a11bdeb826743bd04387a386da065ea71a222938fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday before market hours. Here’s what you need to know.",
                "category": "company",
                "datetime": 1785125102,
                "headline": "Earnings To Watch: IQVIA (IQV) Reports Q2 Results Tomorrow"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 71,
            "discarded_article_count": 56
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2.7,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.7,
            "vcp_reason": "波幅收縮(24.8%→10.8%)；跌縮量(近10日4日)；站上MA50；升放量(近10日2日)；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 1406053.3333333333,
              "down_days": 4,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1162990,
              "avg_vol_20": 1507440,
              "avg_vol_30": 1406053.3333333333,
              "range_pct_10": 0.1083956862078604,
              "range_pct_20": 0.13387560196300968,
              "range_pct_30": 0.2477834689775858,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8271307868833805,
              "dist_to_20d_high": 0.009393577210936326,
              "down_shrink_days": 4,
              "breakout_level_20d": 261.88,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.43746133127898756
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.8781126020309693,
              "turnoverUsdM": 233.83133905361998,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.IQV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 244.4872,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.8,
            "take_profit_price": 275.0248,
            "target_multiplier": 1.9,
            "technical_strength": 1.65,
            "take_profit_percent": 6
          },
          "positionPoints": 1.4,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.756225204061939,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 7.4664,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.88
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 158.52
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1643
    },
    "kdj": {
      "d": 83.78,
      "j": 99.96,
      "k": 89.17,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "強資金流入",
      "score": 10,
      "value": 71.24
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 14735438,
      "recentSlope": 328723.8,
      "previousSlope": -340410
    },
    "rsi": 73.83,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 240.0545,
      "position": "SAR喺價下",
      "distancePct": 7.46,
      "previousTrend": "上升"
    },
    "ma50": 216.105,
    "macd": {
      "macd": 11.514244149053468,
      "trend": "強烈看漲",
      "signal": 10.623443676535576,
      "histogram": 0.890800472517892
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 242.4164,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 24
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.69,
      "score": 2,
      "avgVolume": 1297683,
      "currentVolume": 901362
    },
    "derived": {
      "ma20": 243.0455,
      "ma50": 216.105,
      "prevClose": 260.24,
      "avgVolume10": 1144676,
      "avgVolume20": 1297683,
      "changePercent": -0.32,
      "avgVolumeForScore": 1297683
    },
    "ma_cross": {
      "ma20": 243.0455,
      "ma50": 216.105,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 242.2215,
      "prevMa50": 214.5458,
      "spreadPct": 12.47,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 224.5023,
      "upper": 261.5887,
      "position": "上半部"
    },
    "rsi_short": 90.87,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.69
    }
  }
}

{
  "close": 259.42,
  "volume": 901362,
  "changePercent": -0.32
}